Contineum Therapeutics, Inc.
USD13.90
+0.37 (+2.73%)
CEO
Carmine N. Stengone
IPO Date
2024-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.43
Prev. Close
$13.53
Day Low
$13.43
Day High
$13.95
52W Low
$4.76
52W High
$16.91
Market Cap
$0.52B
Volume
0.17M
| 25 |
| $16.00 |
| 10 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Acquired | 25 | $1.01 |
| 10 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Disposed | 1,015 | $1.01 |
| 10 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Disposed | 25 | $1.01 |
| 8 Jul 2026 | Stengone Carmine N. | director, officer: CEO and President | M-Exempt | Acquired | 2,500 | $1.01 |
| 8 Jul 2026 | Stengone Carmine N. | director, officer: CEO and President | S-Sale | Disposed | 2,500 | $16.00 |
| 8 Jul 2026 | Stengone Carmine N. | director, officer: CEO and President | M-Exempt | Disposed | 2,500 | $1.01 |
| 2 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | M-Exempt | Acquired | 28,826 | $1.01 |
| 2 Jul 2026 | Lorrain Daniel S. | Chief Scientific Officer | S-Sale | Disposed | 28,826 | $16.04 |